Introduction
Mechanical ventilatory strategies that use high tidal volumes and transpulmonary pressures directly injure the lung, a phenomenon termed ventilator-induced lung injury (VILI). Developments in our understanding of the pathogenesis of VILI, and clinical outcome data, have increased the use of low lung stretch ventilatory strategies that reduce mechanical trauma and the associated inflammatory effects [1, 2] . These strategies generally necessitate hypoventilation and tolerance of hypercapnia to realize the benefits of low lung stretch. This has resulted in a shift in clinical paradigms regarding hypercapniafrom strict avoidance to acceptance, and a realization that even moderate to marked degrees of hypercapnia are well tolerated. Paralleling this paradigm shift, several investigators have demonstrated the potential for induced hypercapnic acidosis to directly attenuate experimental acute lung injury. These findings raise the possibility that hypercapnia may have an active role in the pathogenesis of inflammation and tissue injury. The effects of hypercapnia in acute lung injury states may be independent of, and distinct from, the demonstrated benefits of reduced lung stretch.
This paper reviews the current clinical status of permissive hypercapnia, discusses the insights gained to date from basic scientific studies of hypercapnia and acidosis, and considers the potential clinical implications of these findings for the management of acute lung injury. Experimental and clinical studies of special interest, published within the annual period of review, have been highlighted.
Permissive hypercapnia: clinical spectrum
Acute lung injury and acute respiratory distress syndrome
Mechanical ventilation potentiates and may even cause lung damage, and it worsens the outcome in patients with ALI and ARDS [3 • , 4] . The potential for protective lung ventilatory strategies, with varying degrees of permissive hypercapnia, to improve survival in patients with ALI/ARDS is increasingly clear [3 • ,4-6] . The direct contribution of hypercapnia per se to these protective effects in the clinical context has not been determined. However, the potential for hypercapnia to directly protect against the effects of high stretch mechanical ventilation has recently received strong support in a preliminary communication. Kregenow et al. [7] examined mortality as a function of permissive hypercapnia on the day of enrollment of patients to the ARDSnet tidal volume study [6] . Using multivariate logistic regression analysis, and controlling for other comorbidities and severity of lung injury, they reported that permissive hypercapnia reduced mortality in patients randomized to the higher tidal volume [7] . However permissive hypercapnia did not affect outcome in patients randomized to the lower tidal volume.
Of concern, there is clear evidence that many clinicians do not use protective ventilatory strategies in patients with ALI/ARDS, despite convincing outcome data supporting their use [5, 6] . Rubenfeld et al. [8 • ] attempted to identify barriers to the implementation of protective ventilatory strategies. Experienced nurses and respiratory therapists, based at hospitals that participated in the ARDS Network trial, were surveyed. Identified barriers to the institution of protective ventilatory strategies included an unwillingness by physicians to relinquish control of ventilator to a set protocol, delays in the diagnosis of ARDS/ALI, and the presence of conditions that were considered by the physicians to be contraindications to a protective lung strategy. Barriers to the continuation of lung protective ventilation included concerns about patient comfort and concerns relating to the potential for hypercapnia, acidosis, and hypoxemia to exert deleterious effects. The therapeutic benefit of protective strategies did not seem to be adequately recognized. This survey has clear limitations and seems to assume that all barriers to the use of protective ventilation are physician-centered. Furthermore, some 'barriers,' such as failure of the physician to relinquish control of the ventilator, may be appropriate, given the therapeutic potential of protective ventilatory strategies. However, these findings deserve careful consideration if the full benefits of lung protective strategies in ALI/ARDS are to be realized.
Status asthmaticus
Although much of the current work regarding ventilatory strategies involving permissive hypercapnia concentrates on its therapeutic potential in ALI/ARDS, its use was first described in patients with status asthmaticus. Permissive hypercapnia continues to play a central role in the ventilatory management of acute severe asthma. Dhuper et al. [9] , in a study of the factors contributing to the need for tracheal intubation and mechanical ventilation in asthma, report a low incidence of barotrauma and no mortality with a ventilation strategy involving permissive hypercapnia (peak airway pressures maintained <50 cm H 2 O irrespective of the PaCO 2 level). Gupta et al. [10] analyzed the factors contributing to outcome in patients with acute severe asthma admitted to 128 intensive care units in England, Wales, and Northern Ireland participating in the ICNARC (Intensive Care National Audit and Research Center) case-mix database. An analysis of PaCO 2 levels in all patients receiving ventilation within 24 hours of admission showed that these patients were treated with a ventilatory strategy that resulted in significant hypercapnia (mean highest PaCO 2 of 8.2 KPa) [10] .
Neonatal respiratory failure
The benefits of permissive hypercapnia in neonatal respiratory failure are well recognized [11] . In fact, the clearest evidence for the use of permissive hypercapnia is in infants with neonatal respiratory distress syndrome, in which a randomized controlled clinical trial of preterm infants demonstrated a clear benefit with permissive hypercapnia [12] . Kamper et al. [13 • ] conducted a prospective multicenter study of the respiratory treatment of neonates of extremely low gestational age (gestational age <28 weeks) and birthweight (birthweight <1000 g) admitted to neonatal intensive care units across Denmark in 1994 through 1995. They reported that a ventilatory support strategy based on permissive hypercapnia with the early use of nasal continuous positive airway pressure, with surfactant therapy and mechanical ventilation reserved for failure of nasal continuous positive airway pressure, was as effective as strategies involving early mechanical ventilation and seemed to significantly reduce the incidence of chronic lung disease [13 • ].
Permissive hypercapnia plays an increasing role in the ventilatory treatment of infants with congenital diaphragmatic hernia. This contrasts sharply with traditional management strategies that involved aggressive hyperventilation with the aim of producing systemic alkalinization. However, high levels of barotrauma, poor long-term respiratory outcomes, and poor survival rates have prompted the recognition that the hypoplastic lung is the major pathophysiologic defect. Accordingly, the avoidance of barotrauma has assumed increasing importance, and ventilation strategies involving permissive hypercapnia are increasingly used in this clinical setting. Bagolan et al. [14 • ] conducted a retrospective analysis of the impact of three different treatment protocols on the outcome in highrisk infants with congenital diaphragmatic hernia. They divided admissions over a 6-year period into three chronologic groups, which were similar in terms of predictive risk factors, based on the treatment protocols used. They reported that a treatment protocol prioritizing permissive hypercapnia produced a substantial increase in survival, decreased barotrauma, and decreased morbidity at 6 months. By contrast, the earlier introduction of high-frequency oscillatory ventilation seemed to have minimal impact. This study has limitations, notably an inability to take account of any impact of other changes in the management of this condition over time, such as delayed surgical intervention. However, the finding of a clear survival benefit with a treatment protocol in which permissive hypercapnia seems to be the sole addition is persuasive [14 • ].
Tolerance to extreme hypercapnia
Several recent reports emphasize the potential for tolerance to extreme levels of hypercapnia, termed supercarbia, in both adults and children. Mazzeo et al. [15] described complete clinical recovery after an episode of prolonged life-threatening status asthmaticus in an 8-year-old boy. Despite maximal medical therapy involving both conventional and ''last-resort'' bronchodilator therapies, a progressive respiratory acidosis developed, with a nadir pH of 6.77 and PaCO 2 of 39 KPa (293 mm Hg) recorded 10 hours after admission. Hemodynamic stability was maintained throughout, and no neurologic or other organ dysfunction was detected after eventual complete resolution of the status asthmaticus. Urwin et al. [16] reported survival without adverse sequelae after extreme hypercapnia (PCO 2 31.05 KPa) in an older woman with acute decompensation of chronic obstructive airway disease. These reports serve to allay fears regarding the potential for hypercapnia to exert direct deleterious effects.
Hypercapnia: insights from the laboratory
To our knowledge, no clinical data have directly compared the effects of comparable lung ventilatory strategies in the presence or absence of hypercapnia. At present, it is not feasible to examine the direct effects of hypercapnic acidosis, independent of ventilator strategy, in humans. However, important insights continue to be gained from evaluation of the direct effects of hypercapnia and acidosis in experimental models of lung and systemic organ injury.
Acute lung injury
Recent studies have contributed to a growing body of evidence suggesting that hypercapnia and acidosis exerts biologically important effects in experimental acute lung injury. The potential for hypercapnic acidosis, induced by the administration of inspired CO 2 , to attenuate ALI induced by primary (ie, lung) ischemia-reperfusion is clear from previous in vivo and ex vivo studies [17] [18] [19] . More recently, hypercapnic acidosis was demonstrated to directly attenuate indices of ALI after secondary (ie, mesenteric) ischemia-reperfusion in an in vivo rat model [20 •• ] . Lung protection with hypercapnic acidosis occurred despite pulmonary artery pressures that were greater than those observed with normocapnia. Reperfusion increased lipid peroxidation in the bowel, liver, and lung, and it caused histologically apparent bowel injury; however, none of these effects was altered by hypercapnia [20 •• ] .
Hypercapnic acidosis protects against VILI in both ex vivo and in vivo models [21, 22] . Recent studies, which used more clinically relevant degrees of tidal stretch, indicate that hypercapnic acidosis exerts more modest protective effects. Strand et al. [23 • ] examined the potential for hypercapnic acidosis to attenuate mild VILI in surfactanttreated preterm lamb lungs. The animals were randomized to receive hypercapnia (mean PaCO 2 levels 95 mm Hg) or control conditions. A modest degree of VILI was induced by ventilation with moderate tidal lung stretch (tidal volume 12-15 mL/kg ÿ1 ) for 30 minutes followed by a conventional tidal volume (6-9 mL/kg ÿ1 ) for 5.5 hours. Hypercapnic acidosis was well tolerated, and postnatal hemodynamic adaptation seemed to be unaffected. Hypercapnic acidosis attenuated the physiologic indices of ALI and reduced the infiltration of inflammatory cells into the airspaces but not the lung tissue. In addition, there was a consistent but nonsignificant trend to reduced indicators of inflammation in the lung tissue and bronchoalveolar lavage fluid with hypercapnic acidosis [23 • ]. Laffey et al. [24] demonstrated the potential for hypocapnia to worsen and for hypercapnia to attenuate VILI, in the context of a clinically relevant ventilatory strategy in the in vivo rabbit. Carbon dioxide modulated key physiologic indices of lung injury; hypocapnia was potentially deleterious, and hypercapnic acidosis was potentially protective. The mechanisms underlying these effects seemed to be independent of alterations in surfactant chemistry [24] .
By contrast, Rai et al. [25 • ] reported that hypercapnic acidosis did not attenuate lung injury induced by surfactant depletion, an atelectasis prone model of ALI, which mimics neonatal respiratory distress syndrome. After surfactant depletion, animals were randomized to an injurious (Vt 12 mL/kg; positive end-expiratory pressure [PEEP] 0 cm H 2 O) or a protective (Vt 5 mL/kg; PEEP 12.5 cm H 2 O) ventilatory strategy and to receive either control conditions or hypercapnic acidosis. Injurious ventilation resulted in significant lung injury, as evidenced by a large alveolar-arterial O 2 gradient, elevated peak airway pressure, increased protein leak, and impaired lung compliance. Hypercapnic acidosis did not attenuate these physiologic indices of ALI. Taken together, these findings suggest that although hypercapnic acidosis substantially attenuates VILI due to excessive stretch, its effects in the context of more clinically relevant lung stretch may be more modest, and it does not attenuate the extent of lung damage due to collapse and reexpansion of atelectatic lung.
The potential for hypercapnic acidosis to exert beneficial effects in the context of a protective lung ventilatory strategy, as distinct from an injurious strategy, remains to be determined.
In the clinical setting, sepsis is the commonest cause of ARDS and is associated with the poorest outcome [26] . The mechanisms that initiate lung injury in sepsisinduced ARDS are quite distinct from those seen in nonsepsis-induced ARDS. Lipopolysaccharide, an endotoxin produced by gram-negative bacteria, is central to the mechanism by which bacteria produce tissue damage. Hypercapnic acidosis attenuated acute lung injury induced by intratracheal endotoxin instillation in the in vivo rat [27 •• ] . Hypercapnic acidosis attenuated the physiologic indices of lung injury, including lung compliance and oxygenation, and reduced lung neutrophil infiltration. In addition, stereologic analysis of lung tissue demonstrated that hypercapnic acidosis markedly attenuated the histologic indices of lung damage [27
The therapeutic potential of hypercapnic acidosis is underlined by the finding that it seems to be effective even when instituted after the lung injury process begins, in the setting of both mesenteric ischemia-reperfusion and endotoxin-induced ALI models [20 •• ,27 •• ]. This finding contrasts with many other initially promising experimental strategies that demonstrate potential when used before the injury process but lose their effectiveness when used after the development of organ injury, thus minimizing their potential clinical utility. The importance of this finding is underlined by the fact that in the clinical context, the process of acute organ injury is generally well established before a patient comes to a critical care facility for specific therapy.
Mechanistic insights
Nuclear factor kappa beta (NF-kB) is a key regulator of the expression of multiple genes involved in the inflammatory response, and its activation represents a pivotal early step in the activation of this response. Takeshita et al. [28 •• ] , in a pivotal paper, demonstrated that hypercapnic acidosis significantly inhibits endotoxin-induced NF-kB activation and DNA binding activity in human pulmonary endothelial cells via a mechanism mediated through a decrease in IkB-a degradation [28 •• ] . Hypercapnic acidosis suppressed endothelial cell production of intercellular adhesion molecule-1 and interleukin-8 mRNA and protein, which are thought to be mainly regulated by the NF-kB-related pathway, and suppressed indices of cell injury [28 •• ] . This represents a key finding, which may constitute the underlying mechanism by which the antiinflammatory effects of hypercapnic acidosis are mediated at a molecular level within the cell [29, 30] .
Hypercapnia: physiologic insights Pulmonary
The potential for increasing hypercapnic acidosis to produce a stepwise augmentation of PaO 2 is clear from two recent experimental studies [20 •• ,31 • ] . A key underlying mechanism is mediated via improved matching of ventilation and perfusion in the lung. Brogan et al. [32 • ] demonstrated that most of the beneficial effect of CO 2 on ventilation-perfusion matching could be achieved by limiting CO 2 to late inspiration, which limits the CO 2 to the conducting airways, thereby minimizing the potential for systemic hypercapnic acidosis. Lee et al. [33] demonstrated the potential for hypercapnia to increase pulmonary arterial pressures and pulmonary vascular resistance. It is reassuring that the potential for hypercapnic acidosis to alter pulmonary hemodynamics did not seem to be exacerbated in the setting of preexisting pulmonary hypertension.
Regulation of ventilation
Hypercapnia is a potent regulator of ventilation. Crosby et al. [34] examined the potential for a 5-day exposure to constant mild elevation of alveolar CO 2 (end tidal PCO 2 elevated by 8 mm Hg) to cause ventilatory adaptation and to alter the chemoreceptor reflex to acute hypoxia and hypercapnia, in 10 healthy human volunteers. They report no major adaptation of ventilation during the exposure to hypercapnia. There was a modest increase in ventilatory chemosensitivity to acute hypoxia but no change in response to acute hypercapnia. A compensatory metabolic alkalosis developed over first 24 to 48 hours and was maintained over the course of the CO 2 exposure.
Tissue oxygenation
Hypercapnic acidosis increases tissue oxygenation, a potentially protective effect in the setting of acute organ ischemia. Hare et al. [31 • ] demonstrated that the mechanism by which hypercapnic acidosis increases cerebral tissue oxygen tension involves a combination of augmentation of PaO 2 and increased regional cerebral blood flow. Ratnaraj et al. [35] reported that hypercapnic acidosis increased oxygen tension in both subcutaneous tissues and the intestinal wall. Intestinal wall oxygen tensions were increased to a greater degree in the small intestine than in the large intestine. Inadequate intestinal oxygenation has been implicated as a factor in gut dysfunction, leading to loss of barrier function in critically ill patients.
Neurovascular regulation
The mechanisms underlying hypercapnic acidosisinduced cerebral vasodilation are increasingly well characterized. Nakahata et al. [36 •• ] demonstrated that the hypercapnic acidosis-induced cerebral precapillary arteriolar vasodilation is a function of the acidosis rather than the hypercapnia per se. Using selective potassium channel blockers and activators, they demonstrated that the ATPsensitive K + channel, but not the Ca 2+ -dependent K + channel, plays a major role in this vasodilation. Extraluminal normocapnic acidosis, by contrast, induced cerebrovascular vasodilation via combined activation of both ATPsensitive and Ca 2+ -activated potassium channels in the rat middle cerebral artery [37] . Sato et al. [38 • ] demonstrated that nitric oxide, synthesized by the neuronal isoform of nitric oxide synthase, may mediate the increase in retinal blood flow that occurs with hypercapnic acidosis. Thus, the precise mechanism by which hypercapnic acidosis causes cerebral vasodilation seems to differ depending on the arterial bed and the type of artery studied.
Neuromuscular effects
Recent studies have highlighted the potential for hypercapnia to exert potentially deleterious neuromuscular effects. Shiota et al. [39 • ] demonstrate the potential for hypercapnia to alter the contractile and histologic properties of the diaphragm in rats exposed to prolonged hypercapnia (7.5% CO 2 for 6 weeks,). Hypercapnia depressed diaphragmatic tension development and time to contraction and relaxation, and altered diaphragmatic muscle fiber composition, increasing slow twitch fibers and decreasing fast twitch fibers. Beekley et al. [40] demonstrated that short-term exposure to moderate hypercapnia (7% inspired CO 2 ) may transiently impair neuromuscular function through effects on afferent transmission or synaptic integrity in healthy volunteers. The potential for hypercapnia to alter diaphragmatic structure and function and to affect neuromuscular transmission in the clinical context, which may complicate weaning from ventilation, remains to be determined.
Adjuncts to permissive hypercapnia: dead space gas replacement At the end of expiration, the ventilator circuit distal to the Y-piece and the anatomic dead space both contain alveolar gas. This CO 2 -rich gas then constitutes the first part of the next delivered breath to the distal lung. The contribution of this dead-space gas to ventilation increases with decreased tidal volume, given that this dead-space is relatively fixed. Techniques that aim to replace this deadspace gas with fresh gas have been advocated as an adjunct to protective ventilatory strategies. These techniques may improve the efficiency of ventilation by increasing effective alveolar ventilation, and they may facilitate further reductions in tidal volume, minimizing transpulmonary pressures. Tracheal gas insufflation (TGI) is a technique that delivers fresh gas into the central airways, either continuously or in a phasic fashion during expiration. Experimental studies in animal models of ALI and in lung models have highlighted the potential role of TGI in clinical practice [41] . In a recent experimental study, Zhu et al. [42] reported that TGI, either alone or in combination with partial liquid ventilation, attenuates the development of ALI resulting from mechanical ventilation of surfactant depleted lungs.
However, despite extensive investigation, concerns persist about the safety and monitoring of TGI and have impeded its introduction into clinical practice. A significant concern is the risk of tracheal trauma with TGI. In this regard, Dyer et al. [43] investigated the distribution of pressures within a model trachea, produced by five different TGI devices. They reported that the Boussignac tracheal tube produced the most even pressure distribution, whereas a reverse-flow catheter produced pressure changes of the smallest magnitude and hence may be safer for clinical use.
Aspiration of dead-space gas (ASPIDS) during expiration and controlled replacement with fresh gas is a related technique designed to minimize dead space. Liu et al. Ventilation through the coaxial endotracheal tube improved ventilation efficiency at comparable ventilator settings and tracheal pressures. There were no adverse hemodynamic effects or auto-PEEP detected with the use of the coaxial tube. The reduction in arterial CO 2 levels with the coaxial double-lumen endotracheal tube was inversely proportional to tidal volume, with greater reductions at lower tidal volumes. Evaluations of the initial safety and efficacy of this promising adjunct in patients with ALI are required.
Conclusion
Ventilatory strategies involving hypercapnia are widely used in the setting of acute respiratory failure, with the aim of realizing the benefits of reduced lung stretch. However, the optimal ventilatory strategy and the precise contribution of hypercapnia to this strategy remain unclear. The potential for hypercapnia to directly contribute to the beneficial effects of protective lung ventilatory strategies is clear from experimental studies demonstrating protective effects in models of acute lung and systemic organ injury. These findings raise the possibility that hypercapnia might be induced for therapeutic effect in this context. However, concerns persist regarding the potential for hypercapnia and/or acidosis to exert deleterious effects, and the need for caution before extrapolation to the clinical context must be emphasized. A clearer understanding of the effects and mechanisms of action of hypercapnia is central to determining its safety and therapeutic utility.
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